+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Model Market by Animal Type, Model Type, Application, End User - Global Forecast to 2030- Product Image
Animal Model Market by Animal Type, Model Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Animal Model Market by Animal Type, Model Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968035
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Model Market grew from USD 3.16 billion in 2024 to USD 3.42 billion in 2025. It is expected to continue growing at a CAGR of 8.07%, reaching USD 5.04 billion by 2030.

Setting the Stage for Innovation in Animal Models

Animal models remain the bedrock of preclinical research, offering indispensable insights into disease mechanisms, therapeutic efficacy, and safety profiles. As scientific inquiry becomes ever more complex, researchers increasingly rely on refined animal systems to bridge translational gaps and accelerate commercialization. This introduction outlines the evolving significance of animal models amid rising demand for predictive validity, stringent ethical standards, and innovative methodologies. It establishes the context for examining the forces reshaping the landscape, from regulatory changes to technological breakthroughs. By articulating the challenges and opportunities inherent in current practices, this section sets the stage for a deep dive into transformative shifts, trade dynamics, and strategic imperatives. The narrative underscores the need for decision-makers to adopt a forward-looking mindset, anticipating where scientific rigor and operational efficiency must converge to sustain progress. Ultimately, the introduction conveys that understanding these foundational trends is essential for stakeholders seeking to optimize their research pipelines and maintain competitive advantage.

Emerging Paradigms Redefining Animal Model Research

Over the last several years, animal model research has experienced seismic shifts driven by regulatory reforms, technological democratization, and heightened scrutiny of translational relevance. Cutting-edge gene editing platforms have made it possible to generate CRISPR-mediated knock-outs in rodents with unprecedented speed, while advances in nonrodent models-particularly in canine and nonhuman primate systems-have refined safety assessments. Digital pathology tools now enable high-resolution, AI-powered image analysis that accelerates data interpretation and improves reproducibility. Simultaneously, rising ethical expectations and the Three Rs principle have prompted researchers to explore alternatives, spurring growth in organ-on-chip and in silico modeling. These converging paradigms are rewriting conventional definitions of preclinical success, compelling institutions to invest in multidisciplinary teams that blend biology, engineering, and data science. As a result, organizations that embrace these emerging paradigms stand to shorten development timelines and enhance predictive power, while those adhering to legacy approaches risk lagging behind. This transformative period thus represents both a challenge and a catalyst for innovation across the industry.

Navigating the Ripple Effects of US Tariff Measures

In 2025, the cumulative impact of U.S. tariff measures on research animals and related supplies has rippled across global supply chains, compelling labs and suppliers to reconfigure sourcing strategies. Heightened duties on imported nonhuman primates and specialized reagents have inflated acquisition costs, intensifying budgetary pressures for academic institutions and contract research organizations alike. Many stakeholders have responded by diversifying procurement channels, forging regional partnerships to mitigate exposure, and scrutinizing alternative model types to preserve continuity in critical programs. This trade environment has also accelerated the adoption of more domestically produced rodent strains, with companies investing in in-country breeding facilities to circumvent escalated fees. Altogether, these shifts have underscored the importance of supply chain resilience, risk management, and strategic localization in maintaining uninterrupted access to essential research inputs. The evolving tariff landscape highlights that proactive contingency planning is no longer optional but a vital component of preclinical project management.

Unpacking Core Segments Driving Market Dynamics

Market dynamics are inherently shaped by distinct categories that reflect both scientific rigor and user requirements. By animal type, models divide into nonrodents-which encompass dogs, nonhuman primates, and rabbits-and rodents, including hamsters, guinea pigs, mice, and rats, each offering unique translational attributes. When viewed through the lens of model type, the landscape spans disease models, genetically engineered variants such as CRISPR, knock-in, knockout, and transgenic systems, as well as pharmacological and surgical approaches that address specific research objectives. Application domains extend from ADME and pharmacokinetic studies to disease research, drug discovery and development, and toxicology assessment, ensuring that each experimental pathway aligns with regulatory and therapeutic milestones. On the end-user side, academic and research institutes champion fundamental investigations, contract research organizations streamline outsourced preclinical programs, hospitals and diagnostic laboratories apply models for translational diagnostics, and pharmaceutical and biotechnology companies integrate them into comprehensive R&D workflows. This segmentation framework reveals where investment, innovation, and unmet needs converge, guiding stakeholders toward the sub-segments with the greatest strategic relevance and growth potential.

Regional Patterns Shaping the Global Animal Model Landscape

Regional dynamics exert a profound influence on how animal model research evolves, shaped by regulatory regimes, infrastructure, and funding landscapes. In the Americas, robust public and private sector investment underpins an ecosystem characterized by ample access to both rodent and nonrodent facilities, enabling high-throughput studies and cutting-edge gene editing applications. The Europe, Middle East and Africa region presents a mosaic of regulatory frameworks, with the European Union’s rigorous welfare standards driving the integration of advanced non-animal alternatives while Middle Eastern and African markets pursue capacity building through international partnerships. In Asia-Pacific, rapid expansion is fueled by increasing biotech innovation, government incentives for domestic breeding centers, and a burgeoning CRO network that caters to global clients. Each of these regions offers distinct advantages and challenges-from cost considerations to ethical perspectives-highlighting the importance of tailored market entry and growth strategies that align with local nuances.

Competitive Dynamics Among Leading Industry Players

Industry leaders are consolidating positions through innovation, strategic alliances, and talent acquisition. Top players have expanded their portfolios by integrating advanced gene editing services alongside traditional breeding and supply capabilities, thereby addressing a broader spectrum of preclinical needs. Some have pursued partnerships with technology firms to embed AI-driven analytics into pathology workflows, elevating data quality and throughput. Others have invested in proprietary transgenic platforms to differentiate on specificity and reproducibility benchmarks. Mergers and acquisitions continue to reshape competitive boundaries, with companies targeting niche CROs to enhance their service depth in toxicology and disease modeling. This consolidation is complemented by an emphasis on global footprint, as organizations establish new facilities in emerging markets to improve supply chain resilience and local compliance. The cumulative effect is a landscape defined by strategic diversification, technological integration, and a heightened focus on customer-centric solutions that anticipate the evolving demands of preclinical research.

Strategic Imperatives to Capitalize on Market Opportunities

To thrive amid these rapid changes, industry leaders must adopt a multifaceted strategy that balances innovation with operational agility. Foremost, stakeholders should prioritize investment in next-generation gene editing and non-animal alternative technologies to enhance predictive validity and uphold ethical standards. Strengthening supply chain resilience through regional breeding capabilities and diversified sourcing arrangements will reduce vulnerability to tariff fluctuations and logistical disruptions. Collaborations between CROs, academic centers, and technology vendors can foster cross-disciplinary expertise, accelerating the translation of novel models into validated services. Integrating digital pathology and AI-powered analytics across experimental pipelines will not only improve data consistency but also unlock new insights at scale. Finally, organizations should tailor solutions to the nuanced needs of end users-whether large pharmaceutical companies or small biotech firms-thereby cementing long-term partnerships and driving sustained growth.

Robust Methodology Underpinning Market Insights

The analysis underpinning these insights leverages a robust, multi-tiered methodology designed to ensure accuracy and relevance. Extensive secondary research forms the foundation, including comprehensive reviews of peer-reviewed journals, regulatory publications, white papers, and patent filings. Primary research encompasses in-depth interviews with industry executives, scientific thought leaders, and regulatory experts, providing qualitative context and real-world perspectives. This qualitative data is triangulated against global market activity, supply chain intelligence, and competitive benchmarking to identify emerging trends and validate findings. Further, a cross-regional framework accounts for variances in regulatory environments, ethical guidelines, and infrastructure maturity. Rigorous data synthesis and iterative expert review cycles ensure that conclusions reflect both macro-level trajectories and micro-level nuances. Together, these methodological pillars offer a transparent and reproducible basis for the report’s strategic recommendations.

Synthesis of Critical Insights and Future Outlook

In conclusion, the animal model research environment stands at a pivotal juncture defined by technological breakthroughs, evolving trade conditions, and diverse stakeholder needs. The integration of gene editing, AI-driven analytics, and non-animal alternatives is reshaping experiment design and accelerating translational outcomes. Tariff pressures have underscored the necessity of agile supply chain strategies, while segmentation and regional analyses reveal where targeted investments can yield the greatest returns. Competitive dynamics illustrate how leading firms are innovating through partnerships and portfolio expansion, and the actionable recommendations highlight clear paths for leaders seeking to fortify their market positions. Collectively, these insights chart a comprehensive roadmap for informed decision-making, equipping organizations to navigate uncertainty, capitalize on emerging opportunities, and drive next-generation research forward.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Nonrodents
      • Dogs
      • Nonhuman Primates
      • Rabbits
    • Rodents
      • Hamsters & Guinea Pigs
      • Mice
      • Rats
  • Model Type
    • Disease Models
    • Genetically Engineered Models
      • CRISPR Models
      • Knock-In Models
      • Knockout Models
      • Transgenic Models
    • Pharmacological Models
    • Surgical Models
  • Application
    • ADME & PK Studies
    • Disease Research
    • Drug Discovery & Development
    • Toxicology Assessment
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Charles River Laboratories International, Inc.
  • Envigo RMS, Inc.
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Laboratory Corporation of America Holdings
  • Wuxi AppTec Co., Ltd.
  • Evotec AG
  • Crown Bioscience, Inc.
  • Janvier Labs SAS
  • GemPharmatech Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Animal Model Market, by Animal Type
8.1. Introduction
8.2. Nonrodents
8.2.1. Dogs
8.2.2. Nonhuman Primates
8.2.3. Rabbits
8.3. Rodents
8.3.1. Hamsters & Guinea Pigs
8.3.2. Mice
8.3.3. Rats
9. Animal Model Market, by Model Type
9.1. Introduction
9.2. Disease Models
9.3. Genetically Engineered Models
9.3.1. CRISPR Models
9.3.2. Knock-In Models
9.3.3. Knockout Models
9.3.4. Transgenic Models
9.4. Pharmacological Models
9.5. Surgical Models
10. Animal Model Market, by Application
10.1. Introduction
10.2. ADME & PK Studies
10.3. Disease Research
10.4. Drug Discovery & Development
10.5. Toxicology Assessment
11. Animal Model Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals & Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. Americas Animal Model Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Animal Model Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Animal Model Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Charles River Laboratories International, Inc.
15.3.2. Envigo RMS, Inc.
15.3.3. The Jackson Laboratory
15.3.4. Taconic Biosciences, Inc.
15.3.5. Laboratory Corporation of America Holdings
15.3.6. Wuxi AppTec Co., Ltd.
15.3.7. Evotec AG
15.3.8. Crown Bioscience, Inc.
15.3.9. Janvier Labs SAS
15.3.10. GemPharmatech Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANIMAL MODEL MARKET MULTI-CURRENCY
FIGURE 2. ANIMAL MODEL MARKET MULTI-LANGUAGE
FIGURE 3. ANIMAL MODEL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANIMAL MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANIMAL MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANIMAL MODEL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANIMAL MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANIMAL MODEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANIMAL MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANIMAL MODEL MARKET SIZE, BY NONRODENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANIMAL MODEL MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANIMAL MODEL MARKET SIZE, BY NONHUMAN PRIMATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANIMAL MODEL MARKET SIZE, BY RABBITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANIMAL MODEL MARKET SIZE, BY RODENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANIMAL MODEL MARKET SIZE, BY HAMSTERS & GUINEA PIGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANIMAL MODEL MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANIMAL MODEL MARKET SIZE, BY RATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANIMAL MODEL MARKET SIZE, BY DISEASE MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANIMAL MODEL MARKET SIZE, BY CRISPR MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANIMAL MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANIMAL MODEL MARKET SIZE, BY KNOCKOUT MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANIMAL MODEL MARKET SIZE, BY PHARMACOLOGICAL MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANIMAL MODEL MARKET SIZE, BY SURGICAL MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANIMAL MODEL MARKET SIZE, BY ADME & PK STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANIMAL MODEL MARKET SIZE, BY DISEASE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANIMAL MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANIMAL MODEL MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANIMAL MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANIMAL MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANIMAL MODEL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANIMAL MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ANIMAL MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 55. CANADA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 58. CANADA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 101. GERMANY ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 107. FRANCE ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 108. FRANCE ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. FRANCE ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ITALY ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. ITALY ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 119. ITALY ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 120. ITALY ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 121. ITALY ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 122. ITALY ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ITALY ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. QATAR ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. QATAR ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 168. QATAR ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 169. QATAR ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 170. QATAR ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 171. QATAR ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. QATAR ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 178. FINLAND ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FINLAND ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 198. EGYPT ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 199. EGYPT ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. EGYPT ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 205. TURKEY ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 206. TURKEY ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. TURKEY ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 220. NORWAY ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NORWAY ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. POLAND ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 223. POLAND ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 224. POLAND ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 225. POLAND ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 226. POLAND ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 227. POLAND ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. POLAND ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. CHINA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 246. CHINA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 247. CHINA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 248. CHINA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 249. CHINA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. CHINA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. INDIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 252. INDIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 253. INDIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 254. INDIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 255. INDIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 256. INDIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. INDIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 262. JAPAN ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 263. JAPAN ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. JAPAN ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 290. THAILAND ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 291. THAILAND ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. THAILAND ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN ANIMAL MODEL MARKET SIZE, BY NONRODENTS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN ANIMAL MODEL MARKET SIZE, BY RODENTS, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN ANIMAL MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MODELS, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. ANIMAL MODEL MARKET SHARE, BY KEY PLAYER, 2024
TABLE 329. ANIMAL MODEL MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Animal Model market report include:
  • Charles River Laboratories International, Inc.
  • Envigo RMS, Inc.
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Laboratory Corporation of America Holdings
  • Wuxi AppTec Co., Ltd.
  • Evotec AG
  • Crown Bioscience, Inc.
  • Janvier Labs SAS
  • GemPharmatech Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.04 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Digital Display Animal Brain Stereotaxic Instrument Market by Instrument Type, Animal Model, Application, End User, Sales Channel - Global Forecast to 2030 - Product Image

Digital Display Animal Brain Stereotaxic Instrument Market by Instrument Type, Animal Model, Application, End User, Sales Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Preclinical Medical Device Testing Services Market by Testing Technique, Device Category, End User, Animal Model Type, Application - Global Forecast to 2030 - Product Image

Preclinical Medical Device Testing Services Market by Testing Technique, Device Category, End User, Animal Model Type, Application - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Animal Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Animal Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Animal Model - Global Strategic Business Report - Product Image

Animal Model - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Animal Model Market Report 2025 - Product Image

Animal Model Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Animal Model Market

The Animal Model market is a key component of the Drug Discovery process. Animal models are used to study the effects of drugs on living organisms, and to assess the safety and efficacy of potential treatments. Animal models are used to study the pharmacokinetics and pharmacodynamics of drugs, as well as to evaluate the toxicity of compounds. Animal models are also used to study the mechanisms of disease, and to develop new treatments. Animal models are used in a variety of research areas, including cancer, cardiovascular disease, infectious diseases, and neurological disorders. The Animal Model market is highly competitive, with a range of companies offering a variety of services. Companies in the market include Charles River Laboratories, Envigo, Taconic Biosciences, and GenOway. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.